AU2001288413A1 - Diagnostic markers for multiple epilepsy phenotypes - Google Patents

Diagnostic markers for multiple epilepsy phenotypes

Info

Publication number
AU2001288413A1
AU2001288413A1 AU2001288413A AU8841301A AU2001288413A1 AU 2001288413 A1 AU2001288413 A1 AU 2001288413A1 AU 2001288413 A AU2001288413 A AU 2001288413A AU 8841301 A AU8841301 A AU 8841301A AU 2001288413 A1 AU2001288413 A1 AU 2001288413A1
Authority
AU
Australia
Prior art keywords
diagnostic markers
phenotypes
epilepsy phenotypes
multiple epilepsy
markers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001288413A
Inventor
Wade H. Berrettini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pennsylvania Penn
Original Assignee
University of Pennsylvania Penn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pennsylvania Penn filed Critical University of Pennsylvania Penn
Publication of AU2001288413A1 publication Critical patent/AU2001288413A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2857—Seizure disorders; Epilepsy

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001288413A 2000-08-28 2001-08-24 Diagnostic markers for multiple epilepsy phenotypes Abandoned AU2001288413A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22853800P 2000-08-28 2000-08-28
US60228538 2000-08-28
PCT/US2001/026609 WO2002018650A1 (en) 2000-08-28 2001-08-24 Diagnostic markers for multiple epilepsy phenotypes

Publications (1)

Publication Number Publication Date
AU2001288413A1 true AU2001288413A1 (en) 2002-03-13

Family

ID=22857587

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001288413A Abandoned AU2001288413A1 (en) 2000-08-28 2001-08-24 Diagnostic markers for multiple epilepsy phenotypes

Country Status (3)

Country Link
US (1) US7262290B2 (en)
AU (1) AU2001288413A1 (en)
WO (1) WO2002018650A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5214723B2 (en) 2007-04-30 2013-06-19 ナノゲン・インコーポレイテッド Multi-analyte assay
US9732138B2 (en) * 2010-02-09 2017-08-15 Yale University Loss of function mutations in KCNJ10 cause SeSAME, a human syndrome with sensory, neurological, and renal deficits
EP2530088A1 (en) * 2011-05-30 2012-12-05 Klinikum rechts der Isar der Technischen Universität München Means and methods for diagnosing and treating multiple sclerosis
RU2499262C1 (en) * 2012-08-07 2013-11-20 Федеральное Государственное Бюджетное Учреждение "Научно-Исследовательский Институт Психического Здоровья" Сибирского Отделения Российской Академии Медицинских Наук Method for prediction of epilepsy severity
EP3137910B1 (en) * 2014-04-30 2019-09-25 Klinikum rechts der Isar der Technischen Universität München Diagnosis of multiple sclerosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210016A (en) 1990-02-07 1993-05-11 Board Of Regents, The University Of Texas System Allelic association of the human dopamine (D2) receptor gene in compulsive disorders such as alcoholism
US5500343A (en) * 1990-02-07 1996-03-19 Board Of Regents, The University Of Texas System Allelic association of the human dopamine(D2) receptor gene in compulsive disorders
US6500938B1 (en) * 1998-01-30 2002-12-31 Incyte Genomics, Inc. Composition for the detection of signaling pathway gene expression

Also Published As

Publication number Publication date
US7262290B2 (en) 2007-08-28
WO2002018650A1 (en) 2002-03-07
US20040014075A1 (en) 2004-01-22

Similar Documents

Publication Publication Date Title
AU2001238693A1 (en) Urinary catheter system
AU2002213152A1 (en) Mri stent
IL155837A0 (en) A diagnostic system for the ear
AU6629901A (en) A catheter system
AU2002332083A1 (en) Guide-in-guide catheter system
AU2001290685A1 (en) Methods for inhibiting inflammatory disease
AU2001280598A1 (en) Anti-occlusion catheter
AU7065501A (en) Reusable catheter
AU2000277330A1 (en) Catheter system
AUPQ679000A0 (en) Biocidal protection system
AU6633600A (en) Restriction indicator
AU2002231529A1 (en) Multiple determinants for metabolic phenotypes
AU2001282149A1 (en) Improved marker
AU2001288413A1 (en) Diagnostic markers for multiple epilepsy phenotypes
GB0117790D0 (en) Diagnostic marker
AU2001295815A1 (en) Multiple purpose catheter
AU2579401A (en) Brain protein markers
AU2002218457A1 (en) Methods for identifying pesticidal compounds
AU4437001A (en) Bend stiffener
AU7127500A (en) Automated court system
AU2001231192A1 (en) Mob-5/hmob-5 as a cancer diagnostic marker
AU2000222749A1 (en) Mechanically regulated time indicator
AU2002228911A1 (en) Methods for inhibiting pain
AU4113900A (en) Metabolic selection markers for plants
AU2001236884A1 (en) Flexible multi-packing system